Morantel Sustained Release Bolus Research Articles

Appetite, digestive efficiency, feed utilization and carcass evaluation of housed calves naturally infected with gastrointestinal nematodes

The progress of two groups of 10 calves, which had previously been exposed to trichostrongyle infections by grazing infected pastures, was monitored from housing in October to slaughter the following April. Each of the animals of one group had received a morantel sustained release bolus, the other control group remained untreated. The high faecal egg counts and serum pepsinogen concentrations, together with the clinical signs of ostertagiosis observed in the controls in October, persisted during the first month of housing but improved thereafter. From late November onwards, no difference in feed intake and digestive efficiency was observed between the groups. The control calves exhibited a significantly greater feed conversion efficiency over the period February–April, (7.5 vs 12.3 kg feed kg −1 liveweight gain, P<0.001). This reduced the liveweight advantage of the MSRB group over the controls at housing to 25 kg.

Pathophysiological and parasitological studies on Ostertagia ostertagi infections in calves

Friesian calves given a low level infection of the abomasal parasite Ostertagia ostertagi over a six week period displayed a mild diarrhoea with high faecal egg counts and elevated plasma pepsinogen values. At necropsy on day 23 abomasal lesions characteristic of ostertagiasis were widespread. At 42 and 84 days oedema and congestion were also prominent. Total worm burdens on days 23 and 42 were similar but a marked decrease had occurred by day 84. Feed digestibility and nitrogen economy were not markedly affected but radioisotopic measurements demonstrated an increase in albumin disappearance and catabolic rates, and plasma faecal clearance during the course of the infection. Prior administration of a morantel sustained release bolus to a group of similarly infected calves reduced the total worm burdens to less than 50 per cent of those recorded in the infected calves on days 23 and 42 and this fell to 3 per cent on day 84. Abomasal damage and the adverse pathophysiological changes associated with infection were prevented in this group.

The difference between two strains of Ostertagia ostertagi in resistance to morantel tartrate

Borgsteede F. H. M. 1988. The difference between two strains of Ostertagia oslertagi in resistance to morantel tartrate. International Journal for Parasitology 18: 499–502. A comparison was made of the efficacy of morantel tartrate against a susceptible laboratory strain and a field strain of Ostertagia ostertagi isolated during the use of a morantel-sustained release bolus. Twenty calves were divided into four groups. Calves of groups 1 and 2 were infected with the susceptible strain and calves of groups 3 and 4 were infected with the other strain. Calves of groups 2 and 4 were then treated after 28 days with 10 mg kg −1 morantel tartrate and slaughtered on day 34. Faecal egg output of calves of group 2 fell to zero after treatment, while calves of group 4 remained positive, though lower than before. After morantel treatment pepsinogen values dropped markedly in calves of group 2, but less in calves of group 4. Worm numbers of calves of group 2 were reduced by 98.5% compared with those of group 1. Calves of group 4 showed a 77.4% reduction in worm burden compared with calves of group 3. It was concluded that it is possible to select an O. ostertagi strain with morantel resistance by the use of a morantel-sustained release bolus.

Feed intake of grazing calves exposed to trichostrongyle infection and treated with the morantel sustained release bolus

Herbage intake was measured in two groups of 20 first-year grazing cattle. The animals in one group each received a morantel sustained release bolus at turnout to control nematode parasitism and the animals in the other group remained untreated. The latter group showed a mean peak faecal egg count of 655 eggs per gram (e.p.g.) in October associated with high serum pepsinogen concentration and clinical signs of ostertagiasis, compared with a peak of 119 e.p.g. in the treated group which remained in good health. In September the daily voluntary feed intake of the untreated animals was significantly depressed (94 g kg −1 body weight vs. 77 g kg −1 P < 0.001), but no difference in digestive efficiency was recorded between the two groups. This difference in feed intake was associated with a 47 kg mean live weight advantage of the treated animals at housing.

Control of parasitic gastroenteritis in calves with the morantel sustained release bolus: effect of prior grazing with adult cattle.

Control of parasitic gastroenteritis in calves with the morantel sustained release bolus: effect of prior grazing with adult cattle.

Control of gastrointestinal parasitism in calves in Sweden over six years using the morantel sustained release bolus

During the 6 years 1979–1984, the use of the morantel sustained release bolus (MSRB) was monitored in first year grazing calves. Twenty-four to 30 calves each year were allotted to two groups (controls and MSRB-treated) and turned out at the end of May on the same pasture divided into two equal areas. After housing in October, each group was kept in boxes and fed concentrates, whey and hay. The calves were weighed at monthly intervals until the first animals were sent to slaughter. No cases of clinical ostertagiasis Type I were observed in the control calves during the grazing seasons, but in one year (1983) clinical signs occured 2 weeks after housing. The number of overwintering larvae was influenced by pasture contamination the previous season and climatic conditions during winter and spring. The fecal egg output of the control animals during the grazing season did not reflect the level of pasture contamination at turnout. The build-up of pasture larval contamination during the later part of the grazing season was influenced by the climatic conditions. The fecal egg output of the treated calves was low during the entire grazing season resulting in a significantly reduced pasture contamination. A significantly reduced live-weight gain in the control calves was demonstrated at housing in five of the six years. When heavily infected at housing, the performance of the control calves was still influenced negatively during the fattening period indoors.

Evaluation of the morantel sustained release bolus in cows and calves.

The efficacy of the morantel sustained release bolus (MSRB) in controlling gastrointestinal parasitism in beef cattle was assessed during the 1982 spring-autumn grazing season. Forty-eight cows and their calves were allotted to three equal groups. One group (T-1) served as a nonmedicated control group. One MSRB was administered to each calf of the T-2 group, and to each cow and calf of the T-3 group at the beginning of the study. The efficacy of the bolus was assessed by comparison of weight gain performance and parasitological data (fecal worm egg counts, herbage larval counts, worm counts from tracer and principal trial calves, and plasma pepsinogen level determinations). Though not statistically significant, treated calves from Group T-2 had a numerical mean weight gain advantage of 2.6 kg, and those from Group T-3 of 4.7 kg, over control calves. Average daily gains (ADG) for the three groups of calves were 0.69, 0.72, and 0.73 kg, respectively. Untreated cows from Group T-2 and treated cows from Group T-3 outperformed the control cows by 12.3 and 7.5 kg, respectively. Fecal worm egg counts from both groups of treated calves were significantly (P less than 0.01) lower than counts from control calves during the entire 169-day trial; notably, egg counts were reduced by 99% 28 days after MSRB administration to both groups of calves. There were no significant differences in the number of eggs counted from the three groups of cows, probably because of the very low numbers of eggs encountered. Mean total worm burdens of principal calves (six per group) necropsied at trial termination indicated a 91% (P less than 0.01) reduction in Group T-2 and an 87% reduction (P less than 0.01) in Group T-3. Worm-free tracer calves were introduced onto pastures every 28 days to monitor availability of infective larvae. The mean number of worms recovered at necropsy from tracer calves that grazed with control cattle increased as the season progressed. However, the numbers of parasites recovered each month from mid-August through mid-October from tracers that grazed pastures with treated cattle were lower (P less than 0.05) than those levels displayed at trial initiation. In addition, the mean numbers of worms from treated group tracers were lower than from the controls for each necropsy period.(ABSTRACT TRUNCATED AT 400 WORDS)

Efficacy of morantel sustained release bolus against gastrointestinal nematodes in first season grazing Holstein calves

The efficacy of the morantel sustained release bolus (MSRB) in reducing gastrointestinal parasitism in first season grazing calves was evaluated during the summer-autumn grazing seasons of 1982 and 1983 in western Oregon. Each of 38 calves (1982) and 40 calves (1983) were randomly assigned to either control or treatment groups which were given MSRB on the day of turnout onto pasture. Mean worm burdens from tracer calves grazed with treated animals in 1982 and 1983 showed overall reductions of 86.4% ( P > 0.05) and 84.3% ( P < 0.01), respectively, compared to tracers grazed with controls. Ostertagia ostertagi, Cooperia oncophora and Nematodirus helvetianus were the primary nematodes collected at necropsy. Twelve full-season 1982 tracer animals (6 treated and 6 control) indicated an 88.1% ( P < 0.05) overall reduction in mean worm burdens. Mean fecal worm egg per gram (EPG) counts of treated animals reflected a reduction of 69% ( P < 0.05) in 1982 and 90% ( P < 0.05) in 1983. Autumn inhibition of O. ostertagi was observed. In the 1982 trial the control animals showed a slight mean weight gain advantage over the treated group from Day 84 until Day 160 (trial termination) when the mean difference was 7.9 kg. The final mean weight gain advantage of treated animals in 1983 was 13.5 kg ( P < 0.05). These trials demonstrated that the MSRB was an effective anthelmintic for reducing gastrointestinal parasitism in grazing calves and for decreasing pasture larval contamination.

Some observations on the use of the morantel sustained-release bolus in first season-grazing calves on a Belgian dairy cattle farm.

The efficacy of the morantel sustained-release bolus (MSRB) in controlling gastrointestinal parasites in first-season grazing calves was evaluated on a dairy cattle farm in Belgium. The calves grazed a pasture which had been used by bolus-treated animals in the three previous years. The effect of bolus administration was determined with respect to live weight gain, faecal egg shedding, herbage larval counts, serum pepsinogen levels and ELISA antibody titres. In spite of an incomplete reduction of faecal egg shedding during the first months of the grazing season, bolus administration resulted in the prevention of parasitic gastro-enteritis in the calves. A weight gain advantage of 35,2 kg of the bolus-treated animals over the controls was noted already at two months after turnout. This weight gain advantage was maintained until housing. The usefulness of serum pepsinogen values and ELISA antibody titres as parameters in prevention experiments is stressed. Both serological parameters gave more information concerning infection level than did the faecal egg output and the herbage larval counts.

Production, parasitological and carcase evaluation studies in steers exposed to trichostrongyle infection and treated with a morantel bolus or fenbendazole in two consecutive grazing seasons

Friesian steers were exposed to natural trichostrongyle infection and left untreated (controls) or treated with either a morantel sustained release bolus or fenbendazole at two week intervals (clean) in each of two consecutive grazing seasons. In the second grazing season the mean liveweight gains of the clean, morantel treated and control groups of cattle over 152 days were 105, 131 and 109 kg respectively (morantel treated greater than clean, control P less than 0.02). The cattle were slaughtered following an indoor fattening period. The dressed carcase weight, killing out percentage and related carcase measurements were superior in the treated groups. Eighty per cent of the clean and morantel treated cattle graded satisfactorily and qualified for subsidy payment whereas less than 30 per cent of the control cattle were successful. Rib joint analyses showed significantly lower total weight, eye muscle weight and area together with a higher bone content in control cattle.

Metabolism and growth in housed calves given a morantel sustained release bolus and exposed to natural trichostrongyle infection

Three groups of calves, previously grazed on permanent pastures contaminated with bovine trichostrongyle (Ostertagia and Cooperia species) infective larvae, were housed from October to May. During the grazing season one group had received fenbendazole at fortnightly intervals to suppress trichostrongyle infections, one received a morantel sustained release bolus before grazing to limit trichostrongyle contamination of the pasture, and the control group was only medicated when heavy infections caused clinical type 1 ostertagiasis. Digestibility of the whole diet was poorer in the control cattle, particularly for dry matter, crude protein and energy fractions. Balance studies conducted throughout the winter housed period showed that both increased faecal and urinary nitrogen outputs in the control animals contributed to a significantly reduced overall nitrogen retention. The effects were most apparent during clinical type 2 ostertagiasis, which occurred in March in the control group.

New methods of drug application for control of Helminths

Several new ways have been developed of delivering anthelmintics to ruminants aimed particularly at reducing labour. For single doses, these include a semi-automatic rumen injector for giving insoluble drugs to cattle more conveniently and efficiently than by oral dosing, and the dermal application of levamisole wich is, however, subject to seasonal variation in absorption. Sustained administration offers potentially a high level of preventive control but carries a greater risk of developing drug resistance. Even with the best available methods of group adminstration in feed supplements or drinking water, there remains some uncontrollable variation in individual intake. Intraruminal sustained release devices largely overcome this problem and constitute the most inportant new technology. They are represented at present by the commercially successful morantel sustained release bolus, and the more versatile Laby capsule which is under development for anthelmintic delivery. Other new applications include the possible development of synergies, potentiators and drug combinations, the special features of drugs which bind strongly to plasma proteins, and the new possibilities offered by a drug highly effective against all stages of Fasciola hepatica . In the general approach to anthelmintic aplication in helminth control, there have been advances in knowledge of helminth population biology which can lead to better timing of strategic dosing programs, which show that single treatments can have persistent benefits without a stimulation reduction in infection rate, and which question the conventional view that control schemes require the treatment of all animals in the group.

Trichostrongyle larval populations on herbage from grazed and ungrazed cattle pastures in south west Scotland

In the course of studies on the control of bovine parasitic gastroenteritis in south west Scotland using a morantel sustained release bolus the populations of trichostrongyle infective larvae on herbage were monitored over a two-year period. From the results of the herbage analysis and the worm burdens in parasite naive tracer calves introduced at the end of 18 months, it was clear that considerable numbers of infective larvae of Ostertagia ostertagi and Cooperia oncophora survived for at least 18 months on pastures not grazed at all. The results suggest that in south west Scotland after one, or even two, seasons with no further contamination of grazing, permanent cattle pastures cannot be assumed to be helminthologically 'safe' and that this should be taken into consideration when determining prophylactic strategies.

Effects of the use of a morantel sustained release bolus in first and second year grazing cattle

In an experiment carried out in 1981 and 1982, the effect of the use of a morantel sustained release bolus (Paratect ® bolus) on the weight gain and a number of parasitological parameters of cattle was studied. In the first year 42 calves were divided into 3 equal groups, one group was kept outside and treated with a bolus (B), the second group was kept outside and was not treated (C), while the third group remained indoors (I). Groups B and C were grazed separately on contaminated pasture. During the first months Group B had a negligible egg output. The egg output in the controls was much higher and in mid-August they had to be treated for parasitic gastroenteritis. At the end of the grazing season the advantage in weight gain of Group B was 20 kg compared with the controls. During the housing period the growth in the 3 groups was not significantly different. At the start of the second grazing season half the animals of Groups B, C and I received a bolus (Groups BB, CB and IB). The other half remained untreated (BC, CC and IC). The animals treated with a bolus in 1982 gained significantly more weight (64 g/day) than untreated animals. Heifers turned out for the first time (IB and IC) showed much less weight gain than heifers in their second grazing season. The heifers which had previously grazed in 1981 had a very low egg output compared with Groups IB and IC, although the level of egg output of the latter was also not very high (max. almost 40 (eggs per gram (EPG)). In faecal cultures of heifers of Group BC, CB and CC, no Cooperia oncophora-larvae were seen from May onwards, indicating a strong immunity against this species. In Group BB very low numbers of C. oncophora-larvae were observed. In Groups IB and IC, C. oncophora was present during the whole season. At the end of the first season the level of herbage infestation on the control pastures was much higher. In 1982 only slight differences in level of infestation between the pastures were observed. At the start of the season in 1982 serum pepsinogen levels were much higher in the groups which grazed in 1981, compared with the indoor-fed groups. Groups BC and CC had significantly higher levels than Groups BB and CB and all 4 groups always had higher levels than Groups IB and IC. The antibody titres of Ostertagia and C. oncophora followed the same trend as the pepsinogen levels.

Field efficacy of a morantel sustained release bolus for control of gastrointestinal nematodes in yearling steers

The efficacy of a morantel sustained release bolus (MSRB) for control of gastrointestinal nematodes in yearling steers was evaluated over a 6-month grazing period commencing on 26 March 1982. Three groups of 15 steers were allotted to the following treatments: Group 1 — one MSRB at start of trial; Group 2 — one therapeutic dose of thiabendazole at start of trial; Group 3 — untreated control. The treatment groups were grazed separately. Parasite egg counts (EPG), herbage larval counts, pepsinogen levels and weight gains were monitored. Every other month, sets of 2 parasite-free tracer calves were placed in the pasture grazed by each treatment group and allowed to graze for 3 weeks before being subsequently necropsied for worm counts. At the end of the trial, 6 animals from each group were also necropsied for worm counts. The MSRB treatment resulted in significantly lower egg counts, fewer infective larvae on pasture, lower pepsinogen levels and lower worm burdens in tracer calves than was the case for the untreated group, but generally the levels were not significantly different from those associated with the thiabendazole treatment. The mean weight gain for the MSRB treated steers showed a significant advantage (70.9 lb) over the untreated animals, but was not significantly different from those which received thiabendazole. Total worm counts at the end of the trial were not different from any treatment group.

Morantel sustained release bolus: a new approach for the control of trichostrongylosis in Austrian cattle.

The efficacy of a morantel sustained release bolus to control gastrointestinal parasitism during two consecutive grazing seasons was assessed in replacement dairy heifers raised under field conditions in Austria. Thirty calves were randomly allotted into two equal groups and maintained throughout the 1979 summer pasturing season on adjacent pastures of equal size with identical grazing history. Twenty-four of the thirty calves used in 1979 were monitored throughout 1980, each animal remained in the same treatment group as the previous year and grazed the same pastures as the previous year. In both 1979 and 1980 the bolus was administered to each animal in the treated group one week before turnout onto spring pastures, while the control animals received no anthelmintic treatment during either year. The efficacy of the bolus was assessed by comparison of faecal worm egg counts, herbage larval counts, worm counts from tracer and principal trial animals, weight gains and by the incidence of clinical disease found in both tracer and trial animals throughout the grazing season. Milk production was also monitored for all animals in both treatment groups during the first lactation. The system of treatment used in the present study with the morantel sustained release bolus was highly effective in preventing a significant buildup of infective larvae on pasture to the end of the grazing season in both years. In 1979 worm counts of tracer calves grazed on the treated pastures in mid-August were similar to those recorded at the beginning of the season, while worm counts in the control tracers were five times the total found at the beginning of the season. In 1979 the bolus-treated calves outperformed the control group by 34.8 kg (P less than 0.001) over the 168-day grazing period. These results demonstrated that administration of the bolus to calves at the time of turnout onto spring pastures was most effective both in controlling parasites within the cattle themselves and in reducing the level of parasite contamination. During the second grazing season (1980) no beneficial effect in weight gain was observed due to the second bolus treatment. Weight gains realized during the first year, however, largely remained through the second year and the bolus-treated heifers reached breeding weight on average 19 days earlier. No difference in milk yield was observed between the treated and control animals during thier first year of lactation.

The control of parasitic gastroenteritis of grazing cattle in Normandy, France using the morantel sustained release bolus

The efficacy of the morantel sustained release bolus in controlling parasitic gastroenteritis in 153 first-season grazing cattle was assessed in three separate field trials conducted in Normandy, France. In each trial, comparisons were made on weight gain performance and parasitology data (faecal worm egg counts, herbage larval counts and- in two of the trials- worm counts from principal animals sacrificed at the end of the grazing season) when bolus treatment was given either at spring turnout or in mid-season in order to determine the optimum time for bolus administration. Cattle were allocated into three groups, each group maintained on a separate but equivalent paddock constructed from the division of a larger pasture. A morantel sustained release bolus was administered to one group of animals at the time of turnout and to a second group of animals in midsummer. The third group of animals in each trial remained nontreated. The effect of the treatment on the contamination of pasture, and parasite levels and weight gain of the principal trial animals was assessed. Similar results were observed in all three trials. Faecal worm egg counts were reduced during the first part of the grazing season in animals receiving the bolus at turnout compared with mid-season treated animals where egg counts followed a pattern similar to the controls until bolus treatment at which time counts abruptly dropped to a low level. Likewise, levels of infective larvae on pastures grazed by control and mid-season treated animals followed similar patterns, increasing to a high level in late summer, while larval levels on pastures grazed by early-season treated animals remained at low levels throughout most of the season. Serum pepsinogen levels, worm counts and weight gain reflected the results from faecal worm egg and herbage larval counts indicating that early-season treatment with the bolus provided the most efficient treatment time for controlling parasitic gastroenteritis throughout the grazing season. The overall mean weight gain advantage of the early-season bolus-treated animals over the controls was 37.2 kg (P less than 0.01) while the advantage of the mid-season treated animals over controls was 13.7 kg.

The susceptibility of Ostertagia and Cooperia to morantel tartrate after extended exposure to the morantel sustained release bolus.

Abstract The effect of continued use of the morantel sustained release bolus on the susceptibility of Ostertagia and Cooperia to morantel tartrate was investigated under laboratory and field conditions. The efficacy (ED 90 ) of morantel tartrate against a laboratory strain of Ostertagia was determined by dose response titration in controlled experiments before and after five passages through calves in the presence of boluses modified to release morantel on a continuous basis at rates determined to be sublethal to Ostertagia . There was no significant difference between initial susceptibility (ED 90 2.7mg/kg) and final susceptibility (ED 90 3.3mg/kg). In a field study, the morantel sustained release bolus was administered at turnout to a group of 10 cattle that grazed pasture which had been grazed by bolus treated cattle for the previous three seasons. An equal group of nontreated cattle grazed an adjacent identical pasture which had been grazed by nonmedicated control cattle for the previous three seasons. Tracer calves as well as principal cattle grazing the treated and control pastures were housed for three weeks following which half of the cattle from each pasture were treated orally with 2.5 mg/kg morantel tartrate. Efficacy comparisons of worm counts between morantel treated and nontreated animals and from the tracer calves grazing treated and control pastures demonstrated that the efficacy of morantel against the population of Ostertagia exposed to the bolus was equal to the efficacy against the unexposed population. Under the conditions of these studies the susceptibility of Ostertagia to morantel was not altered by the repeated application of the morantel sustained release bolus in four successive seasons.

The morantel sustained release bolus in the control of gastro-intestinal nematodiasis of cattle in Switzerland (preliminary results).

The efficacy of the morantel sustained release bolus was evaluated in 20 first-season grazing calves and 92 cattle in two separate trials. All animals grazed contaminated pastures and were exposed at the time of spring turnout to a risk of infection from gastrointestinal nematodes. In the first study 45 bolus-treated and 47 nontreated control (second or third season) cattle grazed similar but separate communal pastures, while in the second study nine bolus-treated and 11 nontreated control cattle grazed together on a single pasture. Efficacy determinations were conducted by frequent observations throughout the grazing season on faecal worm egg output, serum pepsinogen levels and liveweight gain. In the older group of animals (Trial 1), small differences were recorded between treated and control animals in faecal worm egg output and levels of serum pepsinogen as monitored throughout the grazing season. A significant mean liveweight advantage of 20.27 kg (P less than 0.001) was observed in the bolus-treated group. However, unrecorded pregnancy could not be excluded with certainty as a factor responsible for weight differences. The use of the morantel sustained release bolus provided an adequate protection against parasitic gastroenteritis in the first season grazing calves (Trial 2) despite the fact that bolus-treated animals were co-mingled with control animals. Both the worm egg counts and serum pepsinogen values were lower in the bolus-treated group. The morantel sustained release bolus was well tolerated in both trials.

Grazing study in Ireland using the morantel sustained release bolus for controlling nematodiasis in calves.

The morantel sustained release bolus was administered at turnout to first-season grazing calves in order to assess its efficacy in the seasonal control of infection by nematode parasites in Ireland. The pastures grazed by control calves showed a marked increase in gastrointestinal trichostrongylid infective larvae by September, while numbers of infective larvae on pasture grazed by bolus-treated calves remained at a low level throughout the grazing season. In consequence, the controls showed significantly higher worm egg counts in late season and significantly higher worm burdens (mainly Ostertagia spp) at necropsy carried out in November on representative number of principal animals selected from each group. These reduced worm burdens were attributed to the suppression of egg output during the early part of the season as a result of treatment with the morantel sustained release bolus at turnout in the spring. Pasture contamination with Dictyocaulus viviparus larvae was present on all treatment pastures. The bolus-treated calves however were subjected to an increase in D. viviparus infection which occurred on their pasture in late season after the active life of the bolus had expired. It was concluded that bolus treatment delayed (rather than prevented) the buildup of D. viviparus infection on the pasture by 60-90 days.